Cost of revenue, including cost of revenue from related parties of 19,569 and 32,052 for the three and six months ended june 30, 2026, respectively and 16,518 and 25,917 for the three and six months ended june 30, 2025 respectively
158,301
124,025
144,523
156,011
Grossprofit
134,618
107,238
99,907
113,149
Salesandmarketing
23,778
20,688
16,143
22,311
Researchanddevelopment
42,254
36,549
44,018
39,651
Generalandadministrative
18,843
13,824
16,711
22,264
Totaloperatingexpenses
84,875
71,061
76,872
84,226
Income from operations
49,743
36,177
23,035
28,923
Interestincome
7,142
4,719
4,187
3,100
Interestexpense
2,059
1,933
1,789
1,851
Realized gain on short-term investments (note 11)
0
-
112
0
Unrealized loss on short-term investments (note 11)
69,592
-1,406
-2,849
18,656
Other expense, net
-9,793
-9,300
-5,813
-3,411
Income from equity method investments
21,097
1,749
3,895
3,670
Incomebeforeincometaxes
135,722
30,006
20,778
49,087
Incometaxexpense (note 15)
13,472
3,771
6,566
2,689
Net income
122,250
26,235
14,212
46,398
Less net income attributable to non-controlling interests
33,266
8,928
6,163
10,509
Net income attributable to acm research, inc
88,984
17,307
8,049
35,889
Basic EPS
1.31
0.26
0.124
0.56
Diluted EPS
1.23
0.24
0.121
0.52
Basic Average Shares
67,890,917
65,804,254
65,121,211
64,381,296
Diluted Average Shares
71,838,908
69,769,907
66,415,629
68,414,313
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.